(Tuesday, June 12, 2018)
In last month’s NINDS Director’s message I introduced the planning stages of the NIH HEAL
(Wednesday, May 30, 2018)
NINDS Director Walter J. Koroshetz and NCI Director Norman E. Sharpless
(Tuesday, May 15, 2018)
NIH relies heavily on investigator-initiated R01 grants to fuel its science. This democratic approach is responsible in large part for the success of the American biomedical research enterprise.
(Wednesday, May 2, 2018)
As the Nation’s medical research agency, one of NIH’s most important roles is leveraging our resources to respond to emerging public health crises.
(Friday, February 9, 2018)
The toll that neurological disorders exact on patients and their families is truly tragic. Yet, looking forward there is cause for real optimism for some conditions.
(Wednesday, January 31, 2018)
The beginning of a new year has a way of sneaking up on all of us, but we always gain helpful perspectives by stopping to reflect on the year that has passed. In 2017, NINDS made significant strides through funding awards, collaboration, new research initiatives, and leadership additions.
(Thursday, January 18, 2018)
By: Nina Schor, NINDS Deputy Director
(Wednesday, January 3, 2018)
I’m a news junkie, and I love stories, especially those about science. You may not realize it, but every day as part of the NINDS research community, you are generating incredible news.
(Friday, November 10, 2017)
This week, more than thirty thousand neuroscientists are coming to Washington, DC for the annual meeting of the Society for Neuroscience (SfN).
(Monday, October 30, 2017)
If you know anyone with dementia, you probably understand how devastating it is to those affected and their families. Alzheimer’s Disease (AD), the most common and widely-diagnosed neurodegenerative disorder, affects more than 5 million people in the United States.
